Pfizer Inc (PFE)
28.66
+0.46
(+1.63%)
USD |
NYSE |
May 31, 16:00
28.74
+0.08
(+0.28%)
After-Hours: 20:00
Pfizer Unrealized Gain or Loss - Total (Quarterly)
Unrealized Gain or Loss - Total (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Unrealized Gain or Loss - Total (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -- |
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
Date | Value |
---|---|
December 31, 2022 | -- |
September 30, 2022 | -- |
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
Unrealized Gain or Loss Definition
Unrealized Gain or Loss is the change in value of the assets or liabilities held by a company that haven't yet been realized through a transaction. These gains or losses are present on a company's balance sheet but have not resulted from an actual sale. A positive Unrealized Gain or Loss value indicates that the company holds assets that have appreciated in value but have not yet be realized. A negative Unrealized Gain or Loss indicates that the company holds an asset or investment whose valu...
Unrealized Gain or Loss - Total (Quarterly) Range, Past 5 Years
Unrealized Gain or Loss - Total (Quarterly) Benchmarks
Amgen Inc | -- |
Johnson & Johnson | -- |
Eli Lilly and Co | -- |
Viking Therapeutics Inc | -- |
Moderna Inc | -- |